Phibro Animal Health Corporation (PAHC) Stock Overview
Explore Phibro Animal Health Corporation’s financial performance, market position, analyst ratings, and future outlook.
Phibro Animal Health Corporation (PAHC)
Key Financials
Key Financials
Market Cap
1.4B
P/E Ratio
14.47
EPS (TTM)
$2.93
ROE
0.29%
PAHC Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Phibro Animal Health Corporation (NASDAQ: PAHC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Phibro Animal Health Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PAHC on the NASDAQ shows an RSI of 45.08, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $50.59 for the NASDAQ listing.
Key metrics behind Phibro Animal Health Corporation's NASDAQ-traded stock include a P/E ratio of 14.47 and a market capitalization of 1.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PAHC on the NASDAQ.